{
    "2020-03-31": [
        [
            {
                "time": "2023-10-01",
                "original_text": "U.S. court rules for Teva in migraine patent dispute with Eli Lilly",
                "features": {
                    "keywords": [
                        "court",
                        "Teva",
                        "migraine",
                        "patent",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Lilly's Taltz Gets FDA Nod for Plaque Psoriasis in Children",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Taltz",
                        "FDA",
                        "Plaque Psoriasis",
                        "Children"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "The Daily Biotech Pulse: Amarin Faces Legal Setback, Milestone Payment Kicks In For CytomX, Savara, Reata Disclose COVID-19 Disruptions",
                "features": {
                    "keywords": [
                        "Amarin",
                        "Legal Setback",
                        "Milestone Payment",
                        "CytomX",
                        "Savara",
                        "Reata",
                        "COVID-19"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Pay a Bounty to Develop a Covid-19 Vaccine Faster",
                "features": {
                    "keywords": [
                        "Bounty",
                        "Covid-19",
                        "Vaccine",
                        "Faster"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Why These 7 Pharma Stocks Are Outplaying 90% Of The Stock Market",
                "features": {
                    "keywords": [
                        "Pharma Stocks",
                        "Outplaying",
                        "Stock Market"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Sitryx",
                        "Licensing",
                        "Research Collaboration",
                        "Immunometabolic Medicines"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}